Human — controlled trialNull result

Early-phase human work on ipamorelin

Placeholder seed record. A small early-phase human literature exists. The development programme was not carried forward to approval, and the listed work does not establish a durable clinical effect.

Cited by

Ipamorelin
What the research on ipamorelin actually shows
Ipamorelin has a small early-phase human literature that was not carried forward to approval. Development programmes are abandoned for many reasons — commercial, strategic and scientific — and the published record does not establish a durable clinical effect. A discontinued programme is not evidence of efficacy, and it is not evidence of harm either; it is an absence of conclusion.

Compounds examined

Ipamorelin

Study records state what a paper reported. PepIndex does not interpret findings, assess clinical significance, or restate results in language implying an application not present in the source. Last reviewed 23 Jul 2026.